Sangamo Therapeutics Inc. (SGMO)
0.92
-0.10 (-9.80%)
At close: Mar 03, 2025, 3:59 PM
0.95
3.29%
After-hours: Mar 03, 2025, 07:56 PM EST
Sangamo Therapeutics Revenue
Sangamo Therapeutics reported an annual revenue of $176.23M, reflecting a 58.34% growth. For the quarter ending September 30, 2024, Sangamo Therapeutics generated $49.41M in revenue.
Revenue (ttm)
$176.23M
Revenue Growth
58.34%
Price / Sales Ratio
0.54
Revenue / Employee
$435.14K
Employees
405
Market Cap
191.89M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2023 | 176.23M | +58.34% |
| Dec 31, 2022 | 111.3M | +0.54% |
| Dec 31, 2021 | 110.7M | -6.34% |
| Dec 31, 2020 | 118.19M | n/a |